Elizabeth Shpall, MD
Enriched profileDepartment Chair ad interim, Professor of Medicine, Howard Foster Smith and Lee Dennis Smith Chair for Cancer Research, Department of Stem Cell Transplantation and Cellular Therapy · The University of Texas MD Anderson Cancer Center
Elizabeth Shpall is Department Chair ad interim, Professor of Medicine, Howard Foster Smith and Lee Dennis Smith Chair for Cancer Research, Department of Stem Cell Transplantation and Cellular Therapy at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 1,599 publications with 48,319 citations (h-index 103); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Elizabeth Shpall, MD, is Department Chair ad interim, Professor of Medicine, Howard Foster Smith and Lee Dennis Smith Chair for Cancer Research, Department of Stem Cell Transplantation and Cellular Therapy at The University of Texas MD Anderson Cancer Center. The public record shows 1,599 publications with 48,319 citations (h-index 103), centered on Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, Acute Myeloid Leukemia Research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 7 companies, 7 NIH-funded awards (2002–2025).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Hematopoietic Stem Cell Transplantation
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 494.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Sponsor: M.D. Anderson Cancer Center
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year202514 payments
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Genetix Biotherapeutics IncProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor100%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 2002–2025 per NIH RePORTER. The latest:
- 13 Stem Cell Transplantation and Cellular Therapy
University of Tx Md Anderson Can Ctr
FY2025$24,690P30CA016672 - 13 Stem Cell Transplantation and Cellular Therapy
University of Tx Md Anderson Can Ctr
FY2024$23,220P30CA016672 - SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
University of Tx Md Anderson Can Ctr
FY2023$918,606P50CA100632
Congress activity
Updated 27 Aug 2026
217 congress contributions (2004–2025) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Abstract 3763: Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
AACR Annual Meeting
AACR2025Co-author - Abstract 6396: CREM is a regulatory checkpoint of CAR and IL-15 signaling in NK cells
AACR Annual Meeting
AACR2025Co-author - Abstract CT265: KRASG12Dtargeting using engineered exosomes in pancreatic cancer: Results from the iEXPLORE phase 1 trial
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.
Blood cancer discovery
Article2026 - High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.
Clinical cancer research
Article2026 - Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.
JCO precision oncology
Article2025 - Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.
Clinical cancer research
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/elizabeth-shpall-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Elizabeth-J-Shpall-39803528
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Elizabeth-Shpall-2201696548
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/HindRafei/status/1768788421886222722
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - X / Twitter
x.com/MDAndersonNews/status/1601317018459901952
- X / Twitter
x.com/MDAndersonNews/status/1997855871091568749
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- Board Certified
Internal Medicine, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
Medical Oncology, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Manufacturing & Clinical Operations, Institute for Cell Therapy Discovery & Innovation, MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - Scientific Advisory Board
NAVAN Technologies Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →navanbio.com ↗
Media & interviews
press, podcasts and appearances- Contributor/author page
OncLive (oncology news and video interview outlet)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center